| TOFACITINIB CITRATE |
212943 |
001 |
ANDA |
TOFACITINIB CITRATE |
TABLET;ORAL |
EQ 10MG BASE |
No
|
No
|
2021/06/01
|
2021/06/01
|
AJANTA PHARMA LTD |
Discontinued |
| TOFACITINIB CITRATE |
212943 |
001 |
ANDA |
TOFACITINIB CITRATE |
TABLET;ORAL |
EQ 10MG BASE |
No
|
No
|
2021/06/01
(TA)
|
2021/06/01
|
AJANTA PHARMA LTD |
Discontinued |
| TOFACITINIB |
209633 |
001 |
ANDA |
TOFACITINIB |
TABLET;ORAL |
5MG |
No
|
No
|
2021/06/10
(TA)
|
--
|
BRECKENRIDGE PHARMS |
None (Tentative Approval) |
| TOFACITINIB |
214264 |
001 |
ANDA |
TOFACITINIB CITRATE |
TABLET, EXTENDED RELEASE;ORAL |
EQ 11MG BASE |
No
|
No
|
2021/08/19
|
2021/08/19
|
ZYDUS PHARMS |
Discontinued |
| TOFACITINIB |
214264 |
002 |
ANDA |
TOFACITINIB CITRATE |
TABLET, EXTENDED RELEASE;ORAL |
EQ 22MG BASE |
No
|
No
|
2021/08/19
|
2021/08/19
|
ZYDUS PHARMS |
Discontinued |
| Tofacitinib |
215552 |
001 |
ANDA |
Tofacitinib |
TABLET;ORAL |
5MG |
No
|
No
|
2022/10/04
(TA)
|
--
|
YAOPHARMA CO LTD |
None (Tentative Approval) |
| Tofacitinib |
215552 |
002 |
ANDA |
Tofacitinib |
TABLET;ORAL |
10MG |
No
|
No
|
2022/10/04
(TA)
|
--
|
YAOPHARMA CO LTD |
None (Tentative Approval) |
| TOFACITINIB |
217299 |
001 |
ANDA |
TOFACITINIB CITRATE |
TABLET;ORAL |
5MG |
No
|
No
|
2023/01/06
(TA)
|
--
|
MSN PHARMS INC |
None (Tentative Approval) |
| TOFACITINIB |
217299 |
002 |
ANDA |
TOFACITINIB CITRATE |
TABLET;ORAL |
10MG |
No
|
No
|
2023/01/06
(TA)
|
--
|
MSN PHARMS INC |
None (Tentative Approval) |
| TOFACITINIB CITRATE |
209738 |
001 |
ANDA |
TOFACITINIB CITRATE |
TABLET;ORAL |
EQ 5MG BASE |
No
|
No
|
2023/03/13
|
2023/03/13
|
MICRO LABS |
Discontinued |
| TOFACITINIB CITRATE |
209738 |
001 |
ANDA |
TOFACITINIB CITRATE |
TABLET;ORAL |
EQ 5MG BASE |
No
|
No
|
2023/03/13
(TA)
|
2023/03/13
|
MICRO LABS |
Discontinued |
| TOFACITINIB CITRATE |
209829 |
001 |
ANDA |
TOFACITINIB CITRATE |
TABLET;ORAL |
EQ 5MG BASE |
No
|
No
|
2023/03/14
|
2023/03/13
|
ZYDUS PHARMS |
Discontinued |
| TOFACITINIB CITRATE |
216878 |
001 |
ANDA |
TOFACITINIB CITRATE |
SOLUTION;ORAL |
EQ 1MG BASE/ML |
No
|
No
|
2023/09/25
|
2023/09/25
|
HIKMA |
Discontinued |
| TOFACITINIB |
209923 |
001 |
ANDA |
TOFACITINIB |
TABLET;ORAL |
5MG |
No
|
No
|
2024/04/09
(TA)
|
--
|
PRINSTON PHARMA INC |
None (Tentative Approval) |
| TOFACITINIB |
218462 |
001 |
ANDA |
TOFACITINIB CITRATE |
TABLET, EXTENDED RELEASE;ORAL |
EQ 11MG BASE |
No
|
No
|
2024/06/03
|
2024/06/03
|
AUROBINDO PHARMA LTD |
Discontinued |